Details

Autor(en) / Beteiligte

• Bonezzi, Cesare
• Costantini, Amedeo
• Cruccu, Giorgio
• Fornasari, Diego M.M.
• Guardamagna, Vittorio
• Palmieri, Vincenzo
• Polati, Enrico
• Zini, Pierangelo
• Dickenson, Anthony H

Titel

Capsaicin 8% dermal patch in clinical practice: an expert opinion

Ist Teil von

• Expert opinion on pharmacotherapy, 2020-07, Vol.21 (11), p.1377-1387

Ort / Verlag

England: Taylor & Francis

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Neuropathic pain (NP) is caused by a lesion or disease of the somatosensory system, which can severely impact patients' quality of life. The current-approved treatments for NP comprise of both centrally acting agents and topical drugs, including capsaicin 8% dermal patches, which is approved for the treatment of peripheral NP. The authors summarize literature data regarding capsaicin use in patients who suffer from NP and discuss the clinical applications of this topical approach. Overall, the capsaicin 8% dermal patch is as effective in reducing pain intensity as other centrally active agents (i.e. pregabalin). Some studies have also reported fewer systemic side effects, a faster onset of action and superior treatment satisfaction compared with systemic agents. In our opinion, capsaicin 8% dermal patches also present additional advantages, such as a good systemic tolerability, the scarcity of adverse events, the possibility to combine it with other agents, and a good cost-effective profile. It is important to note that, as the mechanism of action of capsaicin 8% is the 'defunctionalization' of small afferent fibers through interaction with TRPV1 receptors, the peripheral expression of this receptor on nociceptor fibers, is crucial to predict patient's response to treatment.